Report Detail
Global Pancreatic Cancer Diagnostic Market Size, Status and Forecast 2019-2025
- RnM2840473 |
- 03 April, 2019 |
- Global |
- 99 Pages |
- QYResearch |
- Other
Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Biopsy and other products.
United States is the largest sales place, with a consumption value market share nearly 32.12% in 2017. Following United States, Europe is the second largest sales place with the consumption market share of 27.65%.
Market competition is intense. Roche, GE Healthcare, Siemens, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2018, the global Pancreatic Cancer Diagnostic market size was 1930 million US$ and it is expected to reach 3590 million US$ by the end of 2025, with a CAGR of 8.1% during 2019-2025.
This report focuses on the global Pancreatic Cancer Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pancreatic Cancer Diagnostic development in United States, Europe and China.
The key players covered in this study
Roche
GE Healthcare
Siemens
BD
Philips Healthcare
Hitachi Medical
Danaher
Abbott
Canon Medical Systems
Myriad Genetics
Qiagen
Asuragen
BioMarker Strategies
Market segment by Type, the product can be split into
Imaging
Tumor Biomarker
Biopsy
Other
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pancreatic Cancer Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Pancreatic Cancer Diagnostic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pancreatic Cancer Diagnostic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Imaging
- 1.4.3 Tumor Biomarker
- 1.4.4 Biopsy
- 1.4.5 Other
- 1.5 Market by Application
- 1.5.1 Global Pancreatic Cancer Diagnostic Market Share by Application (2014-2025)
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Pancreatic Cancer Diagnostic Market Size
- 2.2 Pancreatic Cancer Diagnostic Growth Trends by Regions
- 2.2.1 Pancreatic Cancer Diagnostic Market Size by Regions (2014-2025)
- 2.2.2 Pancreatic Cancer Diagnostic Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Pancreatic Cancer Diagnostic Market Size by Manufacturers
- 3.1.1 Global Pancreatic Cancer Diagnostic Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Pancreatic Cancer Diagnostic Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Pancreatic Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
- 3.2 Pancreatic Cancer Diagnostic Key Players Head office and Area Served
- 3.3 Key Players Pancreatic Cancer Diagnostic Product/Solution/Service
- 3.4 Date of Enter into Pancreatic Cancer Diagnostic Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Pancreatic Cancer Diagnostic Market Size by Type (2014-2019)
- 4.2 Global Pancreatic Cancer Diagnostic Market Size by Application (2014-2019)
5 United States
- 5.1 United States Pancreatic Cancer Diagnostic Market Size (2014-2019)
- 5.2 Pancreatic Cancer Diagnostic Key Players in United States
- 5.3 United States Pancreatic Cancer Diagnostic Market Size by Type
- 5.4 United States Pancreatic Cancer Diagnostic Market Size by Application
6 Europe
- 6.1 Europe Pancreatic Cancer Diagnostic Market Size (2014-2019)
- 6.2 Pancreatic Cancer Diagnostic Key Players in Europe
- 6.3 Europe Pancreatic Cancer Diagnostic Market Size by Type
- 6.4 Europe Pancreatic Cancer Diagnostic Market Size by Application
7 China
- 7.1 China Pancreatic Cancer Diagnostic Market Size (2014-2019)
- 7.2 Pancreatic Cancer Diagnostic Key Players in China
- 7.3 China Pancreatic Cancer Diagnostic Market Size by Type
- 7.4 China Pancreatic Cancer Diagnostic Market Size by Application
8 Japan
- 8.1 Japan Pancreatic Cancer Diagnostic Market Size (2014-2019)
- 8.2 Pancreatic Cancer Diagnostic Key Players in Japan
- 8.3 Japan Pancreatic Cancer Diagnostic Market Size by Type
- 8.4 Japan Pancreatic Cancer Diagnostic Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Pancreatic Cancer Diagnostic Market Size (2014-2019)
- 9.2 Pancreatic Cancer Diagnostic Key Players in Southeast Asia
- 9.3 Southeast Asia Pancreatic Cancer Diagnostic Market Size by Type
- 9.4 Southeast Asia Pancreatic Cancer Diagnostic Market Size by Application
10 India
- 10.1 India Pancreatic Cancer Diagnostic Market Size (2014-2019)
- 10.2 Pancreatic Cancer Diagnostic Key Players in India
- 10.3 India Pancreatic Cancer Diagnostic Market Size by Type
- 10.4 India Pancreatic Cancer Diagnostic Market Size by Application
11 Central & South America
- 11.1 Central & South America Pancreatic Cancer Diagnostic Market Size (2014-2019)
- 11.2 Pancreatic Cancer Diagnostic Key Players in Central & South America
- 11.3 Central & South America Pancreatic Cancer Diagnostic Market Size by Type
- 11.4 Central & South America Pancreatic Cancer Diagnostic Market Size by Application
12 International Players Profiles
- 12.1 Roche
- 12.1.1 Roche Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Pancreatic Cancer Diagnostic Introduction
- 12.1.4 Roche Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.1.5 Roche Recent Development
- 12.2 GE Healthcare
- 12.2.1 GE Healthcare Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Pancreatic Cancer Diagnostic Introduction
- 12.2.4 GE Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.2.5 GE Healthcare Recent Development
- 12.3 Siemens
- 12.3.1 Siemens Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Pancreatic Cancer Diagnostic Introduction
- 12.3.4 Siemens Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.3.5 Siemens Recent Development
- 12.4 BD
- 12.4.1 BD Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Pancreatic Cancer Diagnostic Introduction
- 12.4.4 BD Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.4.5 BD Recent Development
- 12.5 Philips Healthcare
- 12.5.1 Philips Healthcare Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Pancreatic Cancer Diagnostic Introduction
- 12.5.4 Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.5.5 Philips Healthcare Recent Development
- 12.6 Hitachi Medical
- 12.6.1 Hitachi Medical Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Pancreatic Cancer Diagnostic Introduction
- 12.6.4 Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.6.5 Hitachi Medical Recent Development
- 12.7 Danaher
- 12.7.1 Danaher Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Pancreatic Cancer Diagnostic Introduction
- 12.7.4 Danaher Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.7.5 Danaher Recent Development
- 12.8 Abbott
- 12.8.1 Abbott Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Pancreatic Cancer Diagnostic Introduction
- 12.8.4 Abbott Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.8.5 Abbott Recent Development
- 12.9 Canon Medical Systems
- 12.9.1 Canon Medical Systems Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Pancreatic Cancer Diagnostic Introduction
- 12.9.4 Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.9.5 Canon Medical Systems Recent Development
- 12.10 Myriad Genetics
- 12.10.1 Myriad Genetics Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Pancreatic Cancer Diagnostic Introduction
- 12.10.4 Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Business (2014-2019)
- 12.10.5 Myriad Genetics Recent Development
- 12.11 Qiagen
- 12.12 Asuragen
- 12.13 BioMarker Strategies
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Pancreatic Cancer Diagnostic . Industry analysis & Market Report on Pancreatic Cancer Diagnostic is a syndicated market report, published as Global Pancreatic Cancer Diagnostic Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pancreatic Cancer Diagnostic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
